炔雌醇环丙孕酮联合胰岛素增敏剂治疗多囊卵巢综合征疗效观察

doi:10.3969/j.issn.1000-8535.2022.05.023

摘要/Abstract

摘要： 目的探究炔雌醇环丙孕酮联合胰岛素增敏剂治疗多囊卵巢综合征疗效。方法选取广东省第一荣军医院妇科2018年8月—2020年8月收治的100例多囊卵巢综合征患者作为研究对象,采用随机数字表法将患者分为对照组(n=50)和观察组(n=50),2组患者均给予炔雌醇环丙孕酮治疗,观察组此外联合胰岛素增敏剂治疗,比较2组患者治疗前、治疗30 d后血清性激素、抗缪勒管激素(AMH)水平、代谢指标水平以及临床疗效(包括排卵、妊娠等)。结果治疗前,2组患者血清性激素、AMH水平比较,差异不具有统计学意义(P>0.05),治疗后,2组患者AMH、血清性激素水平均有所下降,且观察组低于对照组(P<0.05)。治疗前,2组患者代谢指标比较,差异不具有统计学意义(P>0.05),治疗后2组患者代谢指标水平均有所下降,且观察组低于对照组(P<0.05)。观察组治疗有效率高于对照组(P<0.05)。结论使用单一药物治疗具有局限性,将炔雌醇环丙孕酮与胰岛素增敏剂相联合治疗能够有效降低患者胰岛素代谢指标水平以及性激素水平,提高患者受孕几率,具有良好的治疗效果。

关键词: 炔雌醇环丙孕酮, 胰岛素增敏剂, 多囊卵巢综合征

Abstract: Objective To explore the efficacy of ethinylestradiol and cyproterone combined with insulin sensitizer in the treatment of polycystic ovary syndrome. Methods A total of 100 patients with polycystic ovary syndrome treated in the Department of Gynecology of the First Invalids Hospital of Guangdong Province from August 2018 to August 2020 were selected as the research object. The patients were divided into control group (n=50) and observation group (n=50). The patients in both groups were given ethinylestradiol cyproterone. In addition, the observation group was treated with insulin sensitizer. The levels of serum sex hormone, anti-Müllerian hormone (AMH), metabolic index level and clinical efficacy (including ovulation, pregnancy, etc.) before treatment and 30 days after treatment were compared. Results Before treatment, the levels of serum sex hormone and AMH had no significant difference between two groups (P>0.05). After treatment, the levels of AMH and serum sex hormone both decreased in two groups, and those in observation group were lower than those in control group (P<0.05). Before treatment, it had no significant difference in metabolic indexes (P>0.05). After treatment, the levels of metabolic indexes in the two groups decreased, and those in observation group were lower than those in control group (P<0.05). The effective rate of the observation group was higher than the control group (P<0.05). Conclusions Using single drug treatment has limitations. The combination of ethinylestradiol cyproterone and insulin sensitizer can reduce insulin metabolism and sex hormone levels, improve the probability of pregnancy, which have a good therapeutic effect.

Key words: ethinylestradiol cyproterone, insulin sensitizer, polycystic ovary syndrome

王诗韵, 何珍珍. 炔雌醇环丙孕酮联合胰岛素增敏剂治疗多囊卵巢综合征疗效观察[J]. 广州医药, 2022, 53(5): 109-112.

WANG Shiyun, HE Zhenzhen. Effect of ethinylestradiol and cyproterone combined with insulin sensitizer on polycystic ovary syndrome[J]. Guangzhou Medical Journal, 2022, 53(5): 109-112.

参考文献

[1] 庞芹,韦少雪,侯丽莹,等.炔雌醇环丙孕酮片联合营养干预对多囊卵巢综合征的疗效及对患者AMH水平和排卵率的影响分析[J]. 临床和实验医学杂志,2021,20(3):316-319.
[2] 韦成厚,韩立薇,张婧.维生素D联合二甲双胍及炔雌醇环丙孕酮治疗多囊卵巢综合征不孕的疗效分析[J]. 中国生育健康杂志,2021,32(2):157-159.
[3] 王荣莉,孔春梅.生化汤加减联合口服炔雌醇环丙孕酮片治疗多囊卵巢综合征血虚寒凝血瘀证临床研究[J]. 国际中医中药杂志,2021,43(5):457-461.
[4] 李美芝,李蓉.多囊卵巢综合征诊断的金标准:鹿特丹标准?[J]. 中国实用妇科与产科杂志,2007,23(9):657-659.
[5] 杜晓静,耿慧英,毛丽梅,等. 炔雌醇环丙孕酮片结合益精补肾方治疗多囊卵巢综合征的临床综合分析[J]. 重庆医学,2019,48(1):148-150.
[6] 蔡莹莹,阮青青,张佳美.二甲双胍联合炔雌醇环丙孕酮治疗后促排卵方案对多囊卵巢综合征不孕患者的疗效观察[J]. 浙江医学,2020,42(4):382-385.
[7] 赵红利,孟宜波,张静.炔雌醇环丙孕酮联合二甲双胍治疗非肥胖型多囊卵巢综合征的疗效及安全性[J]. 临床药物治疗杂志,2020,18(6):49-53.
[8] 蔡艳悦,金敏娟.探讨多囊卵巢综合征采用炔雌醇环丙孕酮片联合二甲双胍治疗疗效及其对胰岛素抵抗、激素影响[J].中国生化药物杂志,2016,36(3):67-69.
[9] 李晓燕,张蓓,林莉. 炔雌醇环丙孕酮分别联合二甲双胍、吡格列酮治疗多囊卵巢综合征的疗效和安全性比较[J].中国药房,2016,27(36):5073-5075.
[10] 张郡,宿宓,许良智,等. 炔雌醇环丙孕酮片与去氧孕烯炔雌醇片的长期应用对多囊卵巢综合征的疗效及代谢安全性[J]. 南方医科大学学报,2018,38(8):917-922.
[11] 《多囊卵巢综合征中国诊疗指南》发布[J]. 中华医学信息导报,2018,33(5):9.
[12] 党晓丽. 炔雌醇环丙孕酮和二甲双胍联合治疗多囊卵巢综合征合并不孕症的效果及对激素水平的影响评价[J]. 贵州医药,2019,43(6):915-916.
[13] 史晓雪,任秀朋,闫冰. 炔雌醇环丙孕酮联合二甲双胍或吡格列酮治疗育龄期多囊卵巢综合征并胰岛素抵抗效果比较[J]. 中国药业,2018,27(10):32-35.
[14] 王莉,侯俐,王海燕. 助仙丹与炔雌醇环丙孕酮对多囊卵巢综合征大鼠血清雄激素及卵巢形态的影响对比[J]. 临床和实验医学杂志,2019,18(8):798-801.
[15] 张建华,张瑾,加秋萍,等. 炔雌醇环丙孕酮在降低多囊卵巢综合征合并念珠菌阴道病复发中的临床效果研究[J]. 中国性科学,2017,26(8):32-34.
[16] 佛新艳,唐红伟,李娜. 炔雌醇环丙孕酮联合营养干预对PCOS患者的疗效及对患者AMH水平和排卵率的影响[J]. 临床和实验医学杂志,2019,18(24):2659-2662.
[17] 鲍旭东,徐杨,傅荣. 炔雌醇环丙孕酮联合二甲双胍对多囊卵巢综合征不孕症患者激素水平的影响[J]. 实用临床医药杂志,2018,22(1):104-106,110.
[18] 杜晓静,耿慧英,毛丽梅,等. 炔雌醇环丙孕酮片结合益精补肾方治疗多囊卵巢综合征的临床综合分析[J]. 重庆医学,2019,48(1):148-150.